Real-time PCR in the diagnosis of congenital toxoplasmosis

• Published in: The Brazilian journal of infectious diseases 2023-09, Vol.27 (5), p.1-102804, Article 102804
• Main Authors: De La Fuente Villar, Bianca Balzano, Gomes, Leonardo Henrique Ferreira, Portari, Elyzabeth Avvad, Ramos, Carla Nasser Patrocinio, Rocha, Danielle Nascimento, Pereira, José Paulo, Neves, Elizabeth de Souza, Guida, Letícia da Cunha
• Format: Article
• Language: English
• Subjects: Amniotic fluid; Blood; Congenital toxoplasmosis; Diagnosis; Diseases; Infants (Newborn); INFECTIOUS DISEASES; Molecular diagnosis; Molecular diagnostic techniques; Original; PCR; Perinatal infection; Placenta; Polymerase chain reaction; Toxoplasmosis
• ISSN: 1413-8670; 1678-4391; 1678-4391
• DOI: 10.1016/j.bjid.2023.102804

The diagnosis of congenital toxoplasmosis presents limitations and therefore new options are necessary. The analysis of amniotic fluid by real-time PCR has already proved effective for confirmation of fetal infection. However, its performance in other biological samples is not clear yet. The aim of this study is to better understand the role of real-time PCR in the blood of the mother and newborn as well as in the amniotic fluid and placenta in the diagnosis of congenital toxoplasmosis. This is a descriptive cohort study of pregnant women with toxoplasmosis followed up in Rio de Janeiro, Brazil. Real-time PCR was performed in samples of maternal blood, amniotic fluid, placenta, and blood of newborns. In addition, histopathological examination of placentas was performed, and data collected from babies were collected. 116 pregnant women were followed up and 298 samples were analyzed. One (0.9%) pregnant woman presented positive PCR in the blood, 3 (3.5%) in the amniotic fluid, 1 (2.3%) in the placenta and no newborn had positive PCR in the blood. Histopathological study was suggestive of toxoplasmosis infection in 24 (49%) placentas. Six (5.2%) newborns were diagnosed with congenital toxoplasmosis, and only cases with positive PCR in the amniotic fluid had correlation of the PCR result with the diagnosis of congenital infection. Both maternal and blood samples of newborns and placenta did not prove to be promising in the diagnosis of congenital toxoplasmosis. Further studies are needed to evaluate the real role of molecular diagnosis in other biological materials rather than the amniotic fluid.